Samuel Yanuck, DC, on Why Vascular Care is Central in his Practice

Posted by Calroy Health Sciences on Apr 13, 2022 10:18:22 AM

 

"Think of primary, all-cause mortality contributors."

In this short video, functional immunologist Sam Yanuck points to an obvious but easily missed clinical issue: while focusing on presenting conditions, clinicians may overlook a patient’s lifetime trajectory and largest risk factors.

Samuel Yanuck, DC, FACFN, FIAMA is a practicing clinician and creator of the practitioner-focused education Cogence Immunology.

Key Takeaways from Dr. Yanuck:

  • Most patients will die from CVD or cancer.
  • By over-focusing on the presenting condition, a practitioner may pay too little attention to the largest long-term risk factors.
  • The presenting condition should be addressed in relation to its underlying biology and the patient's total lifetime trajectory.
  • From a prevention mindset, vascular health should play a central role in that larger perspective.

In Dr. Yanuck’s words:

Quote Images - Samuel Yanuck - Turn things around comfortable driving towards cliff

To learn more about upstream vascular interventions, watch a short presentation by Kristine Burke, MD.

Video: Dr. Kristine Burke on the Glycocalyx

About Sam Yanuck DC, FACFN, FIAMA

Dr. Sam Yanuck has been in practice since 1992. He sees patients with complex chronic conditions from all over the world. He is the creator and chief educator of Cogence Immunology, an online functional immunology course for clinicians. Dr. Yanuck is an adjunct assistant professor in the Program on Integrative Medicine, in the Department of Physical Medicine and Rehabilitation, at the University of North Carolina School of Medicine, where he teaches principles of functional immunology and other topics related to the treatment of chronically ill patients.

IMPORTANT NOTICE:
The information on this webpage is for licensed healthcare practitioner education only, and is not to be disseminated to the general public.

Topics: Samuel Yanuck, DC

Arterosil Research Summary 

Free Download 

Numerous cellular, animal and human studies have been conducted to evaluate the biological activities, mode of mechanisms, and therapeutic benefits of Arterosil, a patent-pending nutraceutical. Studies include:

  • MRI Carotid Plaque Regression Study
  • Glycocalyx Regeneration Study
  • Leukocyte Adhesion Study
  • Arterial Elasticity Study
  • Hypertension Study

Download Arterosil's Research Summary here.

Subscribe Here!

Recent Posts